In addition to producing enough carbon-free electricity to power one third of the homes, businesses and hospitals in Ontario, Canada, Bruce Power contributes to the world’s health care system through its decades of isotope production, a legacy it continues to build upon. For over 35 years, Bruce Power has been a reliable source of cobalt-60. In 2022, Bruce Power took another leap forward in its isotope program, expanding capabilities to supply cancer-fighting isotopes through the installation of a first-of-a-kind Isotope Production System (IPS) in one of its commercial nuclear power reactors for the production of a short-lived isotope, lutetium-177. This innovation was made possible through partnerships with Isogen (a Kinectrics and Framatome company), which designed and manufactured the IPS and with ITM, which processes and distributes medical isotopes. As we look to the future, the unique design of the IPS offers flexibility in function, opening the door to a range of development opportunities.